| Haber: |
Haber Kaynağı: Çeşitli Haber Siteleri
STAT+: Pharmalittle: Pfizer to exit consumer-health joint venture with GSK; access to obesity drugs in U.S. remains ‘dismal’
Drugmakers and patient advocacy groups have aggressively lobbied for coverage of weight-loss drugs, but the status quo has not budged.
https://www.statnews.com/pharmalot/2022/06/01/obesity-depression-antitrust-novartis-biogen-sage-covid19-vaccines/?utm_campaign=rss
|
